Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00589225 · ClinicalTrials.gov registry record
Primary Hyperoxaluria Mutation Genotyping
A clinical trial of Primary Hyperoxaluria, sponsored by Mayo Clinic.
- Completed
- Registry status
- 902
- Enrollment target
- 1
- Study location
NCT00589225 is a study of Primary Hyperoxaluria that has completed, run by Mayo Clinic. The registered enrollment target is 902 participants, roughly in line with the 922-participant average among 3 other Primary Hyperoxaluria trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT00589225, a study of Primary Hyperoxaluria, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 902 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will help us determine whether certain genetic mutations, more than others, are a cause of more severe disease in Primary Hyperoxaluria.
Conditions Studied
Interventions
- GENETIC Genetic Analysis
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 902 participants |
| Start Date | 2003-12 |
| Est. Completion | 2014-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00589225
The ClinicalTrials.gov registry entry for NCT00589225 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 902 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 922-participant average among 3 other Primary Hyperoxaluria trials with a reported enrollment target. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Primary Hyperoxaluria appearing as the primary indexed condition, and to 1 intervention - of which Genetic Analysis is the first listed.
NCT00589225 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT00589225 about?
NCT00589225 is a clinical study titled "Primary Hyperoxaluria Mutation Genotyping". This study will help us determine whether certain genetic mutations, more than others, are a cause of more severe disease in Primary Hyperoxaluria.
What is the current status of trial NCT00589225?
This trial is currently completed. The enrollment target is 902 participants. The study started on 2003-12. Estimated completion is 2014-09.
What conditions does trial NCT00589225 study?
This clinical trial studies the following conditions: Primary Hyperoxaluria.
What interventions are being tested in trial NCT00589225?
The interventions under investigation include: Genetic Analysis (GENETIC).
Who is sponsoring clinical trial NCT00589225?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00589225 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Primary Hyperoxaluria
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.